Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2022-04-12 Regulatory Filings
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
NI 44-101 Notice of intent to qualify – English.pdf
Regulatory Filings
2022-04-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release from Irwin Naturals Inc. announcing a planned strategy to add new mental health treatments and collaborate with third-party payors. It discusses business plans, regulatory overview, and forward-looking statements. There are no financial statements, earnings data, or detailed financial analysis present. The document is a corporate announcement about business strategy and regulatory context rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is not a presentation or call transcript. It is a general corporate news release about business plans and regulatory environment, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and corporate update.
2022-03-24 English
Material change report - English.pdf
Regulatory Filings
2022-03-22 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a news release announcing the completion of an acquisition by Irwin Naturals Inc. It details the transaction terms, background on the acquired company, regulatory overview, and forward-looking statements. There are no financial statements, quarterly or annual results, or detailed financial analysis. The document is not a report but an announcement of a corporate transaction (acquisition). This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is over 10,000 characters, indicating it is a full announcement rather than a brief notice or regulatory filing. Therefore, the appropriate classification is TAR with high confidence.
2022-03-17 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the company's intention to file a draft registration statement (Form S-1) for an initial public offering (IPO). It does not contain any financial data, detailed financial statements, or substantive analysis. It is an announcement of a future filing related to capital raising. The document length is short (1524 characters) and it is clearly an announcement rather than a report or filing itself. Therefore, it fits best under Capital/Financing Update (CAP).
2022-03-16 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing a corporate acquisition and strategic business expansion by Irwin Naturals Inc. It details the acquisition of Midwest Ketafusion, including transaction terms, regulatory overview, and forward-looking statements. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is not a report but a press release about a capital transaction and business update. Therefore, it fits best under Capital/Financing Update (CAP) as it discusses acquisition and issuance of shares as consideration.
2022-03-16 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.